Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
16 pending office actions • 10 art units • 16 examiners • 0 of 16 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
International N&h Denmark Aps has 16 pending office actions in Biotechnology & Pharmaceuticals. The docket spans 16 distinct examiners and 10 distinct art units, showing complete examiner dispersion across a more concentrated set of technical units.
NOAKES, SUZANNE MARIE is the busiest examiner, with 1 pending matter. Portfolio management should emphasize consistent biotechnology claim positions while adapting responses to each separate examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (6%) |
| §103 only | 2 (12%) |
| Double-patenting + other | 4 (25%) |
| Multi-statute (no §101) | 9 (56%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOAKES, SUZANNE MARIE | 1 | 73.4% | +18.3% |
| SCHUBERG, LAURA J | 1 | 23.6% | +37.0% |
| MCKNIGHT, CIARA A | 1 | 61.5% | +40.3% |
| REGLAS, GEORGIANA C | 1 | 39.2% | +33.4% |
| PYLA, EVELYN Y | 1 | 55.8% | +47.1% |
| DAVIS, RUTH A | 1 | 60.9% | +31.0% |
| KERSHAW, KELLY P | 1 | 17.7% | +16.0% |
| CURRENS, GRANT CARSON | 1 | 54.9% | +60.1% |
| HEINCER, LIAM J | 1 | 55.8% | +26.0% |
| DEVI, SARVAMANGALA | 1 | 65.5% | +55.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750902 | SUGAR MIXTURES AND METHODS FOR PRODUCTION AND USE THEREOF | HEINCER, LIAM J | 5d overdue |
| 19044070 | LACTOBACILLI FOR TREATING CARDIAC DYSFUNCTION | SCHUBERG, LAURA J | — |
| 18985811 | PROBIOTICS FOR MENTAL HEALTH | MCKNIGHT, CIARA A | — |
| 18977400 | METHODS OF USING THERMOSTABLE SERINE PROTEASES | REGLAS, GEORGIANA C | — |
| 18792084 | ANTI-OXIDANT COMPOSITION | KERSHAW, KELLY P | — |
| 18772349 | DRIED MICROORGANISM WITH EXCIPIENT | CURRENS, GRANT CARSON | — |
| 18711238 | PRODUCTION OF HIGHLY ATTENUATED BEERS | LEBLANC, KATHERINE DEGUIRE | — |
| 18696298 | EFFECT OF A PROBIOTIC COMPOSITION ON VAGINAL LACTOBACILLUS SPECIES | ZEMAN, ROBERT A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18750902 | SUGAR MIXTURES AND METHODS FOR PRODUCTION AND USE THEREOF | HEINCER, LIAM J | 5d overdue |
| 19103587 | EXPRESSION SYSTEMS FOR PHOSPHATASES | NOAKES, SUZANNE MARIE | — |
| 19044070 | LACTOBACILLI FOR TREATING CARDIAC DYSFUNCTION | SCHUBERG, LAURA J | — |
| 18985811 | PROBIOTICS FOR MENTAL HEALTH | MCKNIGHT, CIARA A | — |
| 18977400 | METHODS OF USING THERMOSTABLE SERINE PROTEASES | REGLAS, GEORGIANA C | — |
| 18804707 | METHOD OF TREATMENT | PYLA, EVELYN Y | — |
| 18836135 | USE OF PROBIOTICS FOR MODULATING ALLERGIC IMMUNE RESPONSES | DAVIS, RUTH A | — |
| 18792084 | ANTI-OXIDANT COMPOSITION | KERSHAW, KELLY P | — |
| Art Unit | Apps |
|---|---|
| 1651 | 3 |
| 1791 | 3 |
| 1645 | 3 |
| 1652 | 1 |
| 1631 | 1 |
| 1656 | 1 |
| 1633 | 1 |
| 1699 | 1 |
| 1767 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19103587 | EXPRESSION SYSTEMS FOR PHOSPHATASES | NOAKES, SUZANNE MARIE | 1652 | §103 | Non-Final OA | — | Pending | Feb 13, 2025 |
| 19044070 | LACTOBACILLI FOR TREATING CARDIAC DYSFUNCTION | SCHUBERG, LAURA J | 1631 | §102§103§112 | Non-Final OA | — | Pending | Feb 03, 2025 |
| 18985811 | PROBIOTICS FOR MENTAL HEALTH | MCKNIGHT, CIARA A | 1656 | §101§102§112 | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18977400 | METHODS OF USING THERMOSTABLE SERINE PROTEASES | REGLAS, GEORGIANA C | 1651 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18804707 | METHOD OF TREATMENT | PYLA, EVELYN Y | 1633 | §112DP | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18836135 | USE OF PROBIOTICS FOR MODULATING ALLERGIC IMMUNE RESPONSES | DAVIS, RUTH A | 1699 | §102§103§112DP | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18792084 | ANTI-OXIDANT COMPOSITION | KERSHAW, KELLY P | 1791 | §103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18772349 | DRIED MICROORGANISM WITH EXCIPIENT | CURRENS, GRANT CARSON | 1651 | §103§112 | Final Rejection | — | Pending | Jul 15, 2024 |
| 18750902 | SUGAR MIXTURES AND METHODS FOR PRODUCTION AND USE THEREOF | HEINCER, LIAM J | 1767 | §103§112Other | Final Rejection | 5d overdue | Pending | Jun 21, 2024 |
| 18714926 | LACTOBACILLI FOR SKIN AGING | DEVI, SARVAMANGALA | 1645 | §102§112DP | Non-Final OA | — | Pending | May 30, 2024 |
| 18711238 | PRODUCTION OF HIGHLY ATTENUATED BEERS | LEBLANC, KATHERINE DEGUIRE | 1791 | §102§103 | Non-Final OA | — | Pending | May 17, 2024 |
| 18696298 | EFFECT OF A PROBIOTIC COMPOSITION ON VAGINAL LACTOBACILLUS SPECIES | ZEMAN, ROBERT A | 1645 | §102§112 | Non-Final OA | — | Pending | Mar 27, 2024 |
| 18590736 | GLYCOSIDE HYDOLASES AND THEIR USE IN PREVENTING AND/OR TREATING A PATHOGENIC INFECTION IN AN ANIMAL | WHITE, ASHLEY TAYLOR | 1653 | §103§112DP | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18580960 | LACTOCOCCUS STRAINS | LI, CHANGQING | 1791 | §102§103§112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18580713 | PROBIOTICS FOR USE IN BOOSTING THE IMMUNE SYSTEM | DUFFY, PATRICIA ANN | 1645 | §102§103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 17287619 | ENZYMES FOR INFUSION MASHING IN ADJUNCT BREWING TECHNICAL FIELD | GOUGH, TIFFANY MAUREEN | 1651 | §103§112 | Final Rejection | — | Pending | Apr 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInternational N&h Denmark Aps has 16 pending office actions as of October 2026, spread across 10 art units and 16 examiners.
Suzanne Marie Noakes has the most, with 1 of International N&h Denmark Aps's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
